1Dethlefsen L, Eckburg PB, Bik EM, et al. (2006) Assembly of the human intestinal microbiota. Trends Ecol Evol 21, 517–523.
2van der Waaij D, Berghuis-de Vries JM & Lekkerkerk-van der Wees JE (1971) Colonization resistance of the digestive tract in conventional and antibiotic-treated mice. J Hyg (Lond) 69, 405–411.
3Bowling TE, Raimundo AH, Grimble GK, et al. (1993) Reversal by short-chain fatty acids of colonic fluid secretion induced by enteral feeding. Lancet 342, 1266–1268.
4Pryde SE, Duncan SH, Hold GL, et al. (2002) The microbiology of butyrate formation in the human colon. FEMS Microbiol Lett 217, 133–139.
5Koruda MJ, Rolandelli RH, Bliss DZ, et al. (1990) Parenteral nutrition supplemented with short-chain fatty acids: effect on the small-bowel mucosa in normal rats. Am J Clin Nutr 51, 685–689.
6Duncan SH, Hold GL, Harmsen HJ, et al. (2002) Growth requirements and fermentation products of Fusobacterium prausnitzii, and a proposal to reclassify it as Faecalibacterium prausnitzii gen. nov., comb. nov. Int J Syst Evol Microbiol 52, 2141–2146.
7Whelan K, Judd PA, Tuohy KM, et al. (2009) Fecal microbiota in patients receiving enteral feeding are highly variable and may be altered in those who develop diarrhea. Am J Clin Nutr 89, 240–247.
8Sullivan A, Edlund C & Nord CE (2001) Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect Dis 1, 101–114.
9Scott KP, Duncan SH & Flint HJ (2008) Dietary fibre and the gut microbiota. Nutr Bull 33, 201–211.
10Food and Nutrition Board (2000) Dietary Reference Intake for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids (Macronutrients). Washington, DC: The National Academies Press.
11Slavin JL (2008) Position of the American Dietetic Association: health implications of dietary fiber. J Am Diet Assoc 108, 1716–1731.
12Stroud M, Duncan H & Nightingale J (2003) Guidelines for enteral feeding in adult hospital patients. Gut 52, Suppl. 7, vii1–vii12.
14Hedin C, Whelan K & Lindsay JO (2007) Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials. Proc Nutr Soc 66, 307–315.
15Sokol H, Seksik P, Furet JP, et al. (2009) Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis 15, 1183–1189.
16Di Sabatino A, Morera R, Ciccocioppo R, et al. (2005) Oral butyrate for mildly to moderately active Crohn's disease. Aliment Pharmacol Ther 22, 789–794.
17Cavaglieri CR, Nishiyama A, Fernandes LC, et al. (2003) Differential effects of short-chain fatty acids on proliferation and production of pro- and anti-inflammatory cytokines by cultured lymphocytes. Life Sci 73, 1683–1690.
18Whelan K, Judd PA, Preedy VR, et al. (2005) Fructooligosaccharides and fiber partially prevent the alterations in fecal microbiota and short-chain fatty acid concentrations caused by standard enteral formula in healthy humans. J Nutr 135, 1896–1902.
19Harmsen HJ, Gibson GR, Elfferich P, et al. (2000) Comparison of viable cell counts and fluorescence in situ hybridization using specific rRNA-based probes for the quantification of human fecal bacteria. FEMS Microbiol Lett 183, 125–129.
20Harmsen HJ, Raangs GC, He T, et al. (2002) Extensive set of 16S rRNA-based probes for detection of bacteria in human feces. Appl Environ Microbiol 68, 2982–2990.
21Franks AH, Harmsen HJ, Raangs GC, et al. (1998) Variations of bacterial populations in human feces measured by fluorescent in situ hybridization with group-specific 16S rRNA-targeted oligonucleotide probes. Appl Environ Microbiol 64, 3336–3345.
22Jansen GJ, Wildeboer-Veloo AC, Tonk RH, et al. (1999) Development and validation of an automated, microscopy-based method for enumeration of groups of intestinal bacteria. J Microbiol Methods 37, 215–221.
23Duncan SH, Belenguer A, Holtrop G, et al. (2007) Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces. Appl Environ Microbiol 73, 1073–1078.
24Schneider SM, Girard-Pipau F, Anty R, et al. (2006) Effects of total enteral nutrition supplemented with a multi-fibre mix on faecal short-chain fatty acids and microbiota. Clin Nutr 25, 82–90.
25Walker AW, Duncan SH, Harmsen HJ, et al. (2008) The species composition of the human intestinal microbiota differs between particle-associated and liquid phase communities. Environ Microbiol 10, 3275–3283.
26Aminov RI, Walker AW, Duncan SH, et al. (2006) Molecular diversity, cultivation, and improved detection by fluorescent in situ hybridization of a dominant group of human gut bacteria related to Roseburia spp. or Eubacterium rectale. Appl Environ Microbiol 72, 6371–6376.
27Salvador V, Cherbut C, Barry JL, et al. (1993) Sugar composition of dietary fibre and short-chain fatty acid production during in vitro fermentation by human bacteria. Br J Nutr 70, 189–197.
28Ramirez-Farias C, Slezak K, Fuller Z, et al. (2009) Effect of inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii. Br J Nutr 101, 541–550.
29Swidsinski A, Loening-Baucke V, Verstraelen H, et al. (2008) Biostructure of fecal microbiota in healthy subjects and patients with chronic idiopathic diarrhea. Gastroenterology 135, 568–579.
30Bowling TE, Raimundo AH, Grimble GK, et al. (1994) Colonic secretory effect in response to enteral feeding in humans. Gut 35, 1734–1741.
31Young VB & Schmidt TM (2004) Antibiotic-associated diarrhea accompanied by large-scale alterations in the composition of the fecal microbiota. J Clin Microbiol 42, 1203–1206.
32Sokol H, Pigneur B, Watterlot L, et al. (2008) Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 105, 16731–16736.
33Afzal NA, Davies S, Paintin M, et al. (2005) Colonic Crohn's disease in children does not respond well to treatment with enteral nutrition if the ileum is not involved. Dig Dis Sci 50, 1471–1475.
34Segain JP, Raingeard de la Bletiere D, Bourreille A, et al. (2000) Butyrate inhibits inflammatory responses through NFκB inhibition: implications for Crohn's disease. Gut 47, 397–403.
35Amann RI, Binder BJ, Olson RJ, et al. (1990) Combination of 16S rRNA-targeted oligonucleotide probes with flow cytometry for analyzing mixed microbial populations. Appl Environ Microbiol 56, 1919–1925.
36Manz W, Amann R, Ludwig W, et al. (1996) Application of a suite of 16S rRNA-specific oligonucleotide probes designed to investigate bacteria of the phylum Cytophaga-Flavobacter-Bacteroides in the natural environment. Microbiology 142, 1097–1106.
37Hold GL, Schwiertz A, Aminov RI, et al. (2003) Oligonucleotide probes that detect quantitatively significant groups of butyrate-producing bacteria in human feces. Appl Environ Microbiol 69, 4320–4324.
38Suau A, Rochet V, Sghir A, et al. (2001) Fusobacterium prausnitzii and related species represent a dominant group within the human fecal flora. Syst Appl Microbiol 24, 139–145.
39Harmsen HJ, Wildeboer-Veloo AC, Grijpstra J, et al. (2000) Development of 16S rRNA-based probes for the Coriobacterium group and the Atopobium cluster and their application for enumeration of Coriobacteriaceae in human feces from volunteers of different age groups. Appl Environ Microbiol 66, 4523–4527.
40Langendijk PS, Schut F, Jansen GJ, et al. (1995) Quantitative fluorescence in situ hybridization of Bifidobacterium spp. with genus-specific 16S rRNA-targeted probes and its application in fecal samples. Appl Environ Microbiol 61, 3069–3075.
41Poulsen LK, Lan F, Kristensen CS, et al. (1994) Spatial distribution of Escherichia coli in the mouse large intestine inferred from rRNA in situ hybridization. Infect Immun 62, 5191–5194.